Stock Spotlights Archives - Page 109 of 116

FridayNov 03, 2017 12:16 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool. An article discussing this reads: “InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids (http://cnw.fm/hFe3o). The company recently announced it has enabled the production of all four “gateway” cannabinoids using genetically engineered microorganisms. From these gateway substrates, production of all 90+ cannabinoids is possible via biosynthesis. InMed’s breakthrough stands to make the production of cannabis derivatives, including THC, CBD…

FridayNov 03, 2017 12:15 pm

CannabisNewsBreaks – Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients. Skinvisible out-licenses its formulations, enabling companies like Canopy Hemp Corporation to bring their own patented products to market and combat generic competitors. An article discussing this reads: “With a $80 billion global dermatology market and a $30 billion global skin care over-the-counter (OTC) market, the patented polymer delivery system for topical products developed by Skinvisible, obviously, has many, many possible applications. The company has already…

FridayNov 03, 2017 12:14 pm

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Targets Global Cannabis Market

As a licensed producer under the Marijuana for Medical Purposes Regulations in Canada, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) sells cannabis through its ABcann Medicinals, Inc. subsidiary. “We’re now, hopefully, going to be a global presence,” director Aaron Keay said in an interview with CannabisFN (CFN Media). An article discussing this reads: “ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America (http://cnw.fm/3uiqM). The company sells in…

ThursdayNov 02, 2017 2:19 pm

CannabisNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Enters CBD Market through Strategic Acquisition

Grey Cloak Tech, Inc. (OTCQB: GRCK) recently entered the booming cannabis industry through the strategic acquisition of a medically-focused CBD company, Eqova Life Sciences. An article discussing this reads: “On October 24, 2017, Grey Cloak Tech, Inc. (OTCQB: GRCK) announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products. The company sent a letter of intent pertaining to the acquisition in September. Eqova, a company located in Denver, develops clinical-grade full spectrum hemp oil products, and it distributes via partnerships with licensed medical practitioners.” To view the full article,…

ThursdayNov 02, 2017 2:19 pm

CannabisNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals, because Hyalolex does not need FDA approval. An article discussing this reads: “This hugely accelerated introduction of Hyalolex can only be accomplished in states where medical cannabis is legal and where the ailment (in this case Alzheimer’s) is an approved medical condition. In states where…

WednesdayNov 01, 2017 12:22 pm

CannabisNewsBreaks – Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery

Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company also aims to create a safe delivery method of cannabinoids and is currently working toward this goal with two universities in Canada. An article discussing this reads: “In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat…

FridayOct 27, 2017 9:21 am

CannabisNewsBreaks – Marijuana Company of America (MCOA) Delivers Distinctive Cannabis Investment Opportunities

Having now been legalized for medical and/or recreational use in 29 states and the District of Columbia, cannabis continues to represent an attractive market for investors, with both the legal marijuana and hemp industries marking notable increases. Marijuana Company of America (OTC: MCOA) is a distinctive corporation utilizing a strategic business structure within this burgeoning industry, uniting a diverse portfolio of investments and joint ventures beneath its umbrella that includes several companies involved in hemp cultivation and the development of optimum cultivation and processing facilities. “For companies like MCOA, the path forward is clear – participation in the legal cannabis…

ThursdayOct 26, 2017 12:02 pm

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at the Global Skincare Market

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products. An article discussing this reads: “Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market that's projected to reach $135 billion by 2021 (http://cnw.fm/ud2WJ). SKVI also sees a worldwide dermatology market of $80 billion, plus a $30 billion worldwide over-the-counter (OTC) market (http://cnw.fm/noE7Y). It has already completed the development of 40 products, received numerous technology and product patents and is now ready to monetize its investment. In the U.S. alone, skincare is projected to reach $10.7 billion…

WednesdayOct 25, 2017 12:56 pm

CannabisNewsBreaks – ChineseInvestors.com (CIIX) Targets CBD Health Products Market through New Website, Mobile App

ChineseInvestors.com (OTCQB: CIIX) continues to rapidly grow in 2017, which is primarily attributed to the company’s focus on the cannabidiol (CBD) health products market. An article discussing this reads: “Among the reported highlights is the company’s revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments (http://cnw.fm/uYF8x). CIIX’s business strategy of targeting the emerging cannabidiol (CBD) health products market includes bringing a new website online for its subsidiary ChineseCBDoil.com (http://cnw.fm/7WTcx). This website offers the world’s first 'CBD health products online store in the Chinese language.' At the same time, CIIX launched…

ThursdayOct 19, 2017 12:24 pm

CannabisNewsBreaks – Canada’s Cannabis Market Presents Big Potential for Algae Dynamics Corp. (ADYNF)

In Canada, where recreational marijuana is expected to be legalized in 2018 and where registered clients are projected to increase to 715,000 by 2020 and cumulatively purchase 124,443 kg of dried medical marijuana annually, Algae Dynamics Corp. (OTCQB: ADYNF) foresees huge opportunity and greater market share. If the model seen in Colorado’s cannabis market holds true, by 2018 approximately 45 percent of Canada’s cannabis consumers will have switched from dried medical marijuana to cannabis extracts/oil. This is great news for ADYNF, which produces health products and nutraceuticals utilizing cannabis, hemp and algae oils. An article discussing this reads: “(ADYNF) is…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

Breaks Categories: Stock Spotlights